Sandro Esteves

Prof. Sandro Esteves

ANDROFERT, Campinas, SP, Brazil
+2
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Fertility and Sterility
Verified
Journal Article
Closed access
CACarlo Alviggi
Carlo Alviggi
CAClaus Y. Andersen
Claus Y. Andersen
KBKlaus Buehler
Klaus Buehler
ACAlessandro Conforti
Alessandro Conforti
GPGiuseppe De Placido
Giuseppe De Placido
PHPeter Humaidan
Peter Humaidan

1 January 2016 in Asian Journal of Andrology
Verified
Journal Article
Open access
Ashok AgarwalAshok Agarwal
Ashok Agarwal
DDDamayanthi Durairajanayagam
Damayanthi Durairajanayagam
STSindhuja Tatagari
Sindhuja Tatagari
Sandro EstevesSandro Esteves
Sandro Esteves
AHAvi Harlev
Avi Harlev
ABAsher Bashiri
Asher Bashiri
Traditionally, the success of a researcher is assessed by the number of publications he or she publishes in peer-reviewed, indexed, high impact journals. This essential yardstick, often referred to as the impact of a specific researcher, is assessed through the use of various metrics. While researchers may be acquainted with such matrices, many do not know how to use them to enhance their careers. In addition to these metrics, a number of other factors should be taken into consideration to objectively evaluate a scientist's profile as a researcher and academician. Moreover, each metric has its own limitations that need to be considered when selecting an appropriate metric for evaluation. This paper provides a broad overview of the wide array of metrics currently in use in academia and research. Popular metrics are discussed and defined, including traditional metrics and article-level metrics, some of which are applied to researchers for a greater understanding of a particular concept, including varicocele that is the thematic area of this Special Issue of Asian Journal of Andrology. We recommend the combined use of quantitative and qualitative evaluation using judiciously selected metrics for a more objective assessment of scholarly output and research impact.

14 September 2023 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
MEMichael L Eisenberg
Michael L Eisenberg
Sandro EstevesSandro Esteves
Sandro Esteves
DLDolores J. Lamb
Dolores J. Lamb
JHJames M. Hotaling
James M. Hotaling
AGAleksander Giwercman
Aleksander Giwercman
YCYu-Sheng Cheng
Yu-Sheng Cheng


2 November 2018 in Human Reproduction Update
Verified
Journal Article
Closed access
PDF file
MRMatheus Roque
Matheus Roque
THThor Haahr
Thor Haahr
SGSelmo Geber
Selmo Geber
Sandro EstevesSandro Esteves
Sandro Esteves
PHPeter Humaidan
Peter Humaidan
Elective freezing of all good quality embryos and transfer in subsequent cycles, i.e. elective frozen embryo transfer (eFET), has recently increased significantly with the introduction of the GnRH agonist trigger protocol and improvements in cryo-techniques. The ongoing discussion focuses on whether eFET should be offered to the overall IVF population or only to specific subsets of patients. Until recently, the clinical usage of eFET was supported by only a few randomized controlled trials (RCT) and meta-analyses, suggesting that the eFET not only reduced ovarian hyperstimulation syndrome (OHSS), but also improved reproductive outcomes. However, the evidence is not unequivocal, and recent RCTs challenge the use of eFET for the general IVF population. This systematic review and meta-analysis aimed at evaluating whether eFET is advantageous for reproductive, obstetric and perinatal outcomes compared with fresh embryo transfer in IVF/ICSI cycles. Additionally, we evaluated the effectiveness of eFET in comparison to fresh embryo transfer in different subgroups of patients undergoing IVF/ICSI cycles. We conducted a systematic review, using PubMed/Medline and EMBASE to identify all relevant RCTs published until March 2018. The participants included infertile couples undergoing IVF/ICSI with or without preimplantation genetic testing for aneuploidy (PGT-A). The primary outcome was the live birth rate (LBR), whereas secondary outcomes were cumulative LBR, implantation rate, miscarriage, OHSS, ectopic pregnancy, preterm birth, pregnancy-induced hypertension, pre-eclampsia, mean birthweight and congenital anomalies. Subgroup analyses included normal and hyper-responder patients, embryo developmental stage on the day of embryo transfer, freezing method and the route of progesterone administration for luteal phase support in eFET cycles. Eleven studies, including 5379 patients, fulfilling the inclusion criteria were subjected to qualitative and quantitative analysis. A significant increase in LBR was noted with eFET compared with fresh embryo transfer in the overall IVF/ICSI population [risk ratio (RR) = 1.12; 95% CI: 1.01–1.24]. Subgroup analyses indicated higher LBRs by eFET than by fresh embryo transfer in hyper-responders (RR = 1.16; 95% CI: 1.05–1.28) and in PGT-A cycles (RR = 1.55; 95% CI: 1.14–2.10). However, no differences were observed for LBR in normo-responders (RR = 1.03; 95% CI: 0.91–1.17); moreover, the cumulative LBR was not significantly different in the overall population (RR = 1.04; 95% CI: 0.97–1.11). Regarding safety, the risk of moderate/severe OHSS was significantly lower with eFET than with fresh embryo transfer (RR = 0.42; 95% CI: 0.19–0.96). In contrast, the risk of pre-eclampsia increased with eFET (RR = 1.79; 95% CI: 1.03–3.09). No statistical differences were noted in the remaining secondary outcomes. Although the use of eFET has steadily increased in recent years, a significant increase in LBR with eFET was solely noted in hyper-responders and in patients undergoing PGT-A. Concerning safety, eFET significantly decreases the risk of moderate and severe OHSS, albeit at the expense of an increased risk of pre-eclampsia.

1 January 2019 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Ashok AgarwalAshok Agarwal
Ashok Agarwal
NPNeel Parekh
Neel Parekh
MSManesh Kumar Panner Selvam
Manesh Kumar Panner Selvam
Ralf HenkelRalf Henkel
Ralf Henkel
RSRupin Shah
Rupin Shah
AHAvi Harlev
Avi Harlev
Agarwal A, et al. World J Mens Health. 2019 Sep;37(3):296-312. https://doi.org/10.5534/wjmh.190055